Get the Stockscreener App
1.065
24.20%
-0.34
Pre-market:
1.03
-0.035
-3.29%
Outlook Therapeutics Inc Stock (OTLK) Forecast
The Outlook Therapeutics Inc (OTLK) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $27.56, representing a +2,488% increase from the current price of $1.065. The highest analyst price target is $28.14, and the lowest is $26.98.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OTLK Price Target
Average 30.88
(+2,800% Upside)
Is Outlook Therapeutics Inc (OTLK) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.24 | Neutral |
| STOCH(9,6) | 15.28 | Buy |
| STOCHRSI(14) | 19.98 | Buy |
| MACD(12,26) | 0.0114 | Sell |
| ADX(14) | 30.54 | Buy |
| William %R | -96.99 | Buy |
| CCI(14) | -185.72 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.407
Sell
|
1.3637
Sell
|
| MA20 |
1.482
Sell
|
1.3983
Sell
|
| MA50 |
1.1419
Sell
|
1.1893
Sell
|
| MA100 |
0.7157
Buy
|
0.9868
Buy
|
| MA200 |
0.9401
Buy
|
0.9946
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, OTLK could be considered a Neutral, with 17 technical analysis indicators signaling 8 Buy signals, 8 signaling Sell signals and 1 Neutral signals. This suggests that investors should exercise caution when entering new positions on OTLK, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 38.24 indicates that OTLK is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 15.28 indicates that OTLK is oversold. This indicates that OTLK price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.98 indicates that OTLK is oversold. This suggests that OTLK price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.54 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -185.72 indicates that OTLK is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term OTLK price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Outlook Therapeutics Inc financial reports and earnings history, Outlook Therapeutics Inc (OTLK) stock could reach $18.76 by 2030, $128.20 by 2040 and $163.99 by 2050. See the projected annual prices until 2050 of the Outlook Therapeutics Inc stock below:
- Outlook Therapeutics Inc (OTLK) is expected to reach an average price of $95.42 in 2035, with a high prediction of $95.42 and a low estimate of $94.24. This indicates an $8,859% rise from the last recorded price of $1.065.
- Outlook Therapeutics Inc (OTLK) stock is projected to chart a bullish course in 2040, with an average price target of $128.08, representing an $11,926% surge from its current level. The forecast ranges from a conservative $126.67 to a sky-high $128.20.
- Our analysts predict Outlook Therapeutics Inc (OTLK) to jump 14,050% by 2045, soaring from $148.73 to an average price of $150.69, potentially reaching $150.77. While $148.73 is the low estimate, the potential upside is significant.
- Outlook Therapeutics Inc (OTLK) stock is expected to climb by 2050, reaching an average of $163.88, a $15,288% jump from its current level. However, a wide range of estimates exists, with high and low targets of $163.99 and $161.20, respectively, highlighting the market's uncertainty.
Outlook Therapeutics Inc Stock (OTLK) Year by Year Forecast
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2026
The predicted value for Outlook Therapeutics Inc (OTLK) in 2026 is set at an average of $25.84. Estimates vary from a peak of $30.49 to a trough of $21.18, indicating an +2,326% surge from the present price of $1.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2026 | $28.03 | $26.98 | $28.14 | +2,532% |
| September, 2026 | $28.80 | $27.93 | $28.82 | +2,604% |
| October, 2026 | $29.28 | $28.54 | $30.06 | +2,649% |
| November, 2026 | $30.15 | $29.17 | $30.25 | +2,731% |
| December, 2026 | $30.31 | $30.11 | $30.49 | +2,746% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Outlook Therapeutics Inc (OTLK) is $33.84, with a high forecast of $37.27 and a low forecast of $30.41. This indicates an +3,077% increase from the last price of $1.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $30.87 | $30.41 | $30.93 | +2,798% |
| February, 2027 | $30.89 | $30.88 | $31.45 | +2,801% |
| March, 2027 | $31.56 | $30.69 | $31.63 | +2,863% |
| April, 2027 | $32.04 | $31.59 | $32.06 | +2,909% |
| May, 2027 | $32.64 | $32.08 | $32.86 | +2,964% |
| June, 2027 | $33.80 | $32.77 | $33.95 | +3,074% |
| July, 2027 | $34.46 | $33.94 | $34.79 | +3,135% |
| August, 2027 | $34.97 | $34.60 | $35.12 | +3,184% |
| September, 2027 | $35.73 | $34.93 | $35.74 | +3,255% |
| October, 2027 | $35.64 | $34.87 | $35.71 | +3,246% |
| November, 2027 | $36.48 | $35.75 | $36.48 | +3,326% |
| December, 2027 | $37.20 | $36.49 | $37.27 | +3,393% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2028
In 2028, Outlook Therapeutics Inc (OTLK) is projected to reach an average price of $41.45, with a high projection of $45.60 and a low estimate of $37.30. This indicates an +3,792% rise from the last price of $1.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $37.69 | $37.30 | $37.73 | +3,439% |
| February, 2028 | $38.43 | $37.83 | $38.51 | +3,508% |
| March, 2028 | $39.12 | $38.57 | $39.21 | +3,574% |
| April, 2028 | $39.62 | $39.12 | $39.65 | +3,620% |
| May, 2028 | $40.39 | $39.72 | $40.42 | +3,693% |
| June, 2028 | $41.02 | $40.45 | $41.30 | +3,751% |
| July, 2028 | $41.78 | $41.16 | $41.83 | +3,823% |
| August, 2028 | $42.30 | $41.76 | $42.46 | +3,871% |
| September, 2028 | $42.92 | $42.43 | $43.01 | +3,930% |
| October, 2028 | $43.64 | $43.04 | $43.69 | +3,998% |
| November, 2028 | $44.85 | $43.77 | $44.91 | +4,112% |
| December, 2028 | $45.59 | $44.97 | $45.60 | +4,181% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2029
The 2029 price forecast for Outlook Therapeutics Inc Stock (OTLK) is $39.72 on average, with a high prediction of $63.65 and a low estimate of $15.78. This represents an +3,629% increase from the previous price of $1.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $46.34 | $45.61 | $46.35 | +4,251% |
| February, 2029 | $46.37 | $46.34 | $46.66 | +4,254% |
| March, 2029 | $46.03 | $45.57 | $46.82 | +4,222% |
| April, 2029 | $46.75 | $46.17 | $46.78 | +4,289% |
| May, 2029 | $47.58 | $46.88 | $47.71 | +4,367% |
| June, 2029 | $48.25 | $47.72 | $48.26 | +4,431% |
| July, 2029 | $48.78 | $48.32 | $48.89 | +4,480% |
| August, 2029 | $49.53 | $48.91 | $49.59 | +4,550% |
| September, 2029 | $50.18 | $49.64 | $50.23 | +4,612% |
| October, 2029 | $59.13 | $50.33 | $62.22 | +5,452% |
| November, 2029 | $59.27 | $58.35 | $63.65 | +5,466% |
| December, 2029 | $15.80 | $15.78 | $60.70 | +1,384% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2030
Outlook Therapeutics Inc Stock (OTLK) is expected to reach an average price of $23.34 in 2030, with a high forecast of $30.93 and a low forecast of $15.75. This signifies an +2,092% surge from the last price of $1.065.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.43 | $15.75 | $18.76 | +1,631% |
| February, 2030 | $19.43 | $18.34 | $19.68 | +1,724% |
| March, 2030 | $20.69 | $19.53 | $20.87 | +1,842% |
| April, 2030 | $21.27 | $20.85 | $21.59 | +1,897% |
| May, 2030 | $22.74 | $21.39 | $22.75 | +2,035% |
| June, 2030 | $23.69 | $22.90 | $23.78 | +2,125% |
| July, 2030 | $25.03 | $23.93 | $25.11 | +2,250% |
| August, 2030 | $26.32 | $25.22 | $26.44 | +2,372% |
| September, 2030 | $27.29 | $26.00 | $27.51 | +2,462% |
| October, 2030 | $28.83 | $27.53 | $28.97 | +2,607% |
| November, 2030 | $29.75 | $29.09 | $29.85 | +2,693% |
| December, 2030 | $30.89 | $29.90 | $30.93 | +2,800% |
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):